News

Wilmot Team of Gerber and Carpizo Receives $3M to Further Study Pancreatic Cancer, New Treatment Scheme

Monday, September 15, 2025

Cancer of the pancreas is the most lethal of all major cancers. Why? Factors both inside pancreatic cancer cells and in the neighborhood around the cells create an environment that allows cancer to spread easily and resist treatment.

Wilmot Cancer Institute investigators Darren Carpizo, MD, PhD, and Scott Gerber, PhD, are studying these intrinsic and extrinsic factors—and recently won a $3 million award from the National Cancer Institute to develop a new generation of treatments that can overcome these complex barriers. Both Wilmot members have been investigating pancreatic cancer for years and have already published several important steps to advance research and patient care.